Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Los términos de búsqueda han de ser en inglés.

Italian research group offers chemotherapy, a drug monitoring system for Imatinib and looking for financial agreement

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOIT20200713001
Publicado:
15/07/2020
Caducidad:
16/07/2021
Resumen:
An Italian research group has developed an electrochemical method to measure the concentration of the anti-cancer drug Imatinib in patient´s plasma and then to establish the optimal dose, with an on-site test readable in real time. They are looking for financial agreement to facilitate the production of the prototype.

Details

Tittle:
Italian research group offers chemotherapy, a drug monitoring system for Imatinib and looking for financial agreement
Summary:
An Italian research group has developed an electrochemical method to measure the concentration of the anti-cancer drug Imatinib in patient´s plasma and then to establish the optimal dose, with an on-site test readable in real time. They are looking for financial agreement to facilitate the production of the prototype.
Description:
The effectiveness of many anticancer drugs varies greatly from patient to patient, with risks of incorrect dosages and adverse side effects. The invention provides for the first time an electrochemical method to measure the concentration of the drug Imatinib, an anticancer drug used in particular for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. The therapeutic drug monitoring (TDM) greatly improves the effectiveness of the cancer treatment and helps to personalize the doses and to limit side effects. Quick procedures are therefore essential. The patented electrochemical method provides a simple, fast and cost-effective protocol for the measurement of Imatinib concentration through plasma collection; said method is suitable for the manufacturing of a device, that will make the test results readily and easily accessible at the patient´s bed (point-of-care), avoiding long times required by specialized analysis. The method involves the selective extraction of the drug on a liquid-liquid extraction column and a following measurement of its concentration using an electrochemical technique, in particular adsorptive stripping voltammetry.
The system is under developement / lab tested and they are looking for partnerships with industry or investors in order to realize a prototype and go to market.
Advantages and Innovations:
Simple protocol to be performed also by non-specialized personnel; rapid and accurate diagnosis on site; minimum amount of plasma required; results in real time; determination of drug concentration and therefore of treatment effectiveness for a timely adjustment of individual dosage.
Stage of Development:
Under development/lab tested
IPs:
Patent(s) applied for but not yet granted

Partner sought

Type and Role of Partner Sought:
They are looking for a financial partner to facilitate and speed up the production of the prototipe.

Client

Type and Size of Client:
R&D Institution
Already Engaged in Trans-National Cooperation:
No
Languages Spoken:
English
Italian

Keywords

Technology Keywords:
06002001 Bioquímica / biofísica
06001003 Citología, cancerología, oncología
06001015 Productos farmacéuticos / medicamentos
06001013 Tecnología médica / ingeniería biomédica